101 related articles for article (PubMed ID: 8380686)
1. [The effect and pharmacokinetics of etoposide in patients with primary hepatocellular carcinoma].
Funakoshi S; Aiba K; Dobashi F; Inamoto Y; Hirano A; Tada N; Ogihara A; Fujii T; Kuraishi Y; Yamada T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):165-7. PubMed ID: 8380686
[No Abstract] [Full Text] [Related]
2. [Hepatic arterial infusion of etoposide in the treatment of primary liver neoplasms].
Yasuda H; Fujino H; Tagawa K; Unuma T
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):381-4. PubMed ID: 2155586
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
Aita P; Robieux I; Sorio R; Tumolo S; Corona G; Cannizzaro R; Colussi AM; Boiocchi M; Toffoli G
Cancer Chemother Pharmacol; 1999; 43(4):287-94. PubMed ID: 10071979
[TBL] [Abstract][Full Text] [Related]
4. [The effect of etoposide (Et) on primary hepatocellular carcinoma].
Tanaka N; Furusawa A; Shimoda A; Hirai N; Unoura M; Kato Y; Kobayashi K; Izumi R; Matsui O; Hattori N
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2583-5. PubMed ID: 3039924
[No Abstract] [Full Text] [Related]
5. Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma.
Cheng AL; Chen YC; Yeh KH; Chuang SE; Chen BR; Chen DS
Cancer; 1996 Mar; 77(5):872-7. PubMed ID: 8608477
[TBL] [Abstract][Full Text] [Related]
6. Phase 2 study of high dose etoposide (VP16-213) in hepatocellular carcinoma.
Shiu W; Mok SD; Leung N; Li M; Zacharia A; Li A; Martin C
Jpn J Clin Oncol; 1987 Jun; 17(2):113-5. PubMed ID: 3039199
[TBL] [Abstract][Full Text] [Related]
7. Eleven years experience of oral urea treatment in liver malignancies.
Danopoulos ED; Danopoulou IE
Clin Oncol; 1981 Dec; 7(4):281-9. PubMed ID: 6274553
[No Abstract] [Full Text] [Related]
8. Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC).
Wierzbicki R; Ezzat A; Abdel-Warith A; Ayoub A; Kagevi I; Fadda M; Sieck J; Abdulkareem M; Amin T; Yazigi A
Ann Oncol; 1994 May; 5(5):466-7. PubMed ID: 8075054
[No Abstract] [Full Text] [Related]
9. [Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
Suto T; Yoshida Y; Sakata Y; Ono T; Yoshida T; Yamada N; Chida N; Oohira H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1933-8. PubMed ID: 9797816
[TBL] [Abstract][Full Text] [Related]
10. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Asano N; Fukano M; Kubo M; Sato J; Ito A; Inoue T; Tsujikawa T; Ando A; Sasaki M; Yoshioka U; Koyama S; Fujiyama Y; Bamba T
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1069-73. PubMed ID: 9644322
[TBL] [Abstract][Full Text] [Related]
11. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Tsurumachi T; Yamamoto H; Watanabe K; Honda I; Watanabe S; Yamada S; Jingu K; Satomi D; Fujita M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):631-4. PubMed ID: 8678524
[TBL] [Abstract][Full Text] [Related]
12. Metal contents of liver parenchyma after percutaneous ethanol injection or radiofrequency ablation in patients with hepatocellular carcinoma before and after trientine hydrochloride therapy.
Fukuda H; Ebara M; Okabe S; Yoshikawa M; Sugiura N; Saisho H; Kondo F; Yukawa M
J Lab Clin Med; 2004 Jun; 143(6):333-9. PubMed ID: 15192648
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of liver metastatic ovarian cancer with sequential administration of OK-432 and etoposide].
Yakabe A; Ito T; Hayashi K; Yamashita S; Ito T; Sugino N
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2843-7. PubMed ID: 1963633
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma.
Shiah HS; Chao Y; Chen LT; Yao TJ; Huang JD; Chang JY; Chen PJ; Chuang TR; Chin YH; Whang-Peng J; Liu TW
Cancer Chemother Pharmacol; 2006 Nov; 58(5):654-64. PubMed ID: 16520988
[TBL] [Abstract][Full Text] [Related]
15. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
Lee JL; Ryu MH; Chang HM; Kim TW; Lee SS; Sym SJ; Kim MK; Kim KM; Lee JS; Kang YK
J Gastroenterol Hepatol; 2008 May; 23(5):811-6. PubMed ID: 17995941
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic arterial infusion chemotherapy using totally implantable port system].
Takayasu Y; Yamamoto S; Ikeda J
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
[TBL] [Abstract][Full Text] [Related]
18. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
[TBL] [Abstract][Full Text] [Related]
19. [Study of intra-arterial infusion chemotherapy for hepatocellular carcinoma using an implantable reservoir].
Maruo H; Kosaka A
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1473-6. PubMed ID: 8396899
[TBL] [Abstract][Full Text] [Related]
20. The results of urea-treatment in liver maligancies.
Danopoulos ED; Danopoulou IE
Clin Oncol; 1975 Dec; 1(4):341-50. PubMed ID: 174859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
